CORC

浏览/检索结果: 共25条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Taxonomic notes on the Alocasia-Colocasia Clade (Araceae) in China I: Alocasia yungiana, a new species from Tongbiguan Nhi ure Reserve, Yunnan Province 期刊论文
PHYTOTAXA, 2020, 卷号: 460, 期号: 4, 页码: 277-284
作者:  Ma, Zhengxu;  Li, Yifan;  Dao, Baohui;  Yang, Wanliu;  Liu, Bing
收藏  |  浏览/下载:23/0  |  提交时间:2020/10/22
BORNEO  
Taxonomic notes on the Alocasia-Colocasia Clade (Araceae) in China I: Alocasia yungiana, a new species from Tongbiguan Nhi ure Reserve, Yunnan Province 期刊论文
PHYTOTAXA, 2020, 卷号: 460, 期号: 4, 页码: 277-284
作者:  Ma, Zhengxu;  Li, Yifan;  Dao, Baohui;  Yang, Wanliu;  Liu, Bing
收藏  |  浏览/下载:3/0  |  提交时间:2022/03/01
Repetitive transcranial magnetic stimulation ameliorates recognition memory impairment induced by hindlimb unloading in mice associated with BDNF/TrkB signaling 期刊论文
2019
作者:  Zhai Baohui;  Fu Jingxuan;  Xiang Shitong;  Shang Yingchun;  Yan Yuxing
收藏  |  浏览/下载:13/0  |  提交时间:2020/01/03
Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer 期刊论文
LUNG CANCER, 2018, 卷号: 122, 页码: 32-37
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载:3/0  |  提交时间:2019/11/26
Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer 期刊论文
2018, 卷号: 122, 页码: 32-37
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/03
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 1
作者:  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua;  Wang, Zhehai
收藏  |  浏览/下载:14/0  |  提交时间:2019/12/04
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 页码: S886-S887
作者:  Han, Baohui;  Li, Kai;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载:9/0  |  提交时间:2019/11/26
Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
LANCET ONCOLOGY, 2017, 卷号: 18, 页码: S3-S3
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhao, Yizhuo;  Zhang, Li
收藏  |  浏览/下载:10/0  |  提交时间:2019/11/26
Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
LANCET ONCOLOGY, 2017, 卷号: 18, 页码: S3-S3
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhao, Yizhuo;  Zhang, Li
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/16
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 1, 页码: S886-S887
作者:  Han, Baohui;  Li, Kai;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/12


©版权所有 ©2017 CSpace - Powered by CSpace